NCT04441047View on ClinicalTrials.gov

Universal Anti-Viral Vaccine for Healthy Elderly Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

March 1, 2023

Study Completion Date

November 1, 2024

Conditions
Virus DiseasesPneumoniaCOVID-19 Respiratory InfectionRSV PneumoniaInfluenza, HumanARDS, Human
Interventions
DRUG

AlloStim

Living, activated allogeneic Th1-like memory immune cells

Trial Locations (4)

33186

Coral Research Clinic & Coral Diagnostic, Miami

33445

Delray Physician Care Center, Delray Beach

33542

Florida Medical Clinic, LLC, Zephyrhills

33615

Model Research, Tampa

Sponsors
All Listed Sponsors
lead

Mirror Biologics, Inc.

INDUSTRY

NCT04441047 - Universal Anti-Viral Vaccine for Healthy Elderly Adults | Biotech Hunter | Biotech Hunter